NasdaqCM - Nasdaq Real Time Price USD

Arcadia Biosciences, Inc. (RKDA)

4.1400

+0.0900

+(2.22%)

At close: May 19 at 4:00:00 PM EDT

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Name	Title	Pay	Exercised	Year Born
Mr. Thomas J. Schaefer C.F.A.	CEO, President & Director	455.59k	--	1976
Mr. Mark Kawakami	Chief Financial Officer	326.29k	--	--

5950 Sherry Lane

Suite 215

Dallas, TX 75225

United States

214 974 8921 https://www.arcadiabio.com

Sector:: Consumer Defensive
Industry:
Full Time Employees:: 9

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Arcadia Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

August 11, 2025 at 10:59 AM UTC - August 15, 2025 at 12:00 PM UTC

Arcadia Biosciences, Inc. Earnings Date

May 16, 2025 at 12:00 AM UTC